Ofichem recently attended CDMO Live Europe 2026 in Rotterdam, joining pharmaceutical and biotechnology leaders from across the industry to discuss the future of outsourced development and manufacturing.
The event provided an excellent platform to explore some of the sector’s most important priorities, including strategic partnerships, supply chain resilience, operational agility and the evolving needs of life sciences organisations navigating increasingly complex development and manufacturing landscapes.
Representing our organisation at the event were Lee Ayres, Managing Director, Drug Product Development; Alessia Cogotti, Managing Director, Drug Substance; and Tom Stephens, Head of Business Development & Sales, Drug Substance. Throughout the conference, they engaged in valuable discussions with both existing partners and new contacts from across the global CDMO community.
CDMO Live Europe once again highlighted the importance of strong collaboration across the pharmaceutical supply chain. Conversations throughout the event reinforced the growing need for integrated development and manufacturing solutions that enable companies to progress their programmes efficiently while maintaining flexibility and resilience.
As a partner supporting customers across drug substance, drug product and supply solutions, we welcomed the opportunity to exchange insights, discuss industry challenges and explore innovative approaches to advancing pharmaceutical development and manufacturing.
Our reflections on the event were also featured in an interview, where Lee Ayres and Tom Stephens shared their perspectives on the discussions at CDMO Live Europe and discussed key trends shaping the CDMO market, including supply chain resilience and the benefits of partnering with CDMOs that offer integrated, end-to-end service models. Read the full interview here: https://pharmasource.global/content/expert-insight/cdmo-industry-leaders-on-resilience-capability-gaps-and-the-partnerships-that-will-define-the-next-decade/
We would like to thank everyone who took the time to meet with our team during the event. The conversations and connections made in Rotterdam were both valuable and insightful, and we look forward to continuing these discussions and building new partnerships in the months ahead.
Ready to take your innovation to market?
Work shoulder-to-shoulder with a family-owned CDMO and pharmaceutical supplier that answers quickly, solves early, and keeps your progress steady. Decisions feel clearer with us beside you.